COMPOUND 21, A SELECTIVE ANGIOTENSINII TYPE 2 RECEPTOR AGONIST, DOWNREGULATES LIPOPOLYSACCHARIDE-STIMULATED TISSUE FACTOR EXPRESSION IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS ACTIVATED BY EXPOSURE TO HIGH GLUCOSE